Maryland Firm's Drug Cures Neuropathy In Diabetic Mice In Michigan TestRegeneRx Biopharmaceuticals Inc. (OTC Bulletin Board: RGRX) reported Wednesday that in a Michigan trial, researchers found that Thymosin Beta 4 (Tβ4) promotes statistically significant recovery of peripheral neuropathy in type II diabetic mice.

More From CBS Detroit

Guide: Last Minute Valentine's Day IdeasYou've got less than a week to plan the most romantic night of the year. Better get going!
Best Places To Get A Hot Toddy
Best Sledding Hills

Watch & Listen